Propranolol versus prednisone in the treatment of infantile hemangiomas: A retrospective comparative study

Pediatric Dermatology

Volumn 28, Issue 6, 2011, Pages 649-654

  Bertrand, Janie ^a   McCuaig, Catherine ^a   Dubois, Josée ^a   Hatami, Afshin ^a   Ondrejchak, Sandra ^a   Powell, Julie ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; PROPRANOLOL;

ARTICLE; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DOPPLER FLOWMETRY; FEMALE; GROWTH DISORDER; HUMAN; HYPERTENSION; HYPOTENSION; INFANT; INSOMNIA; IRRITABILITY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SLEEP DISORDER; THRUSH; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; VISUAL ANALOG SCALE; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; HEMANGIOMA, CAPILLARY; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; NEOPLASTIC SYNDROMES, HEREDITARY; PREDNISONE; PROPRANOLOL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 81255127641     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01551.x     Document Type: Article

References (17)

1. Boye E, Jinnin M, Olsen BR,. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009; 20 (Suppl 1): 678-684.
2. Haggstrom AN, Drolet BA, Baselga E, et al., Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118: 882-887. (Pubitemid 46091612)
3. Bennett ML, Fleischer AB Jr, Chamlin SL, et al., Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001; 137: 1208-1213. (Pubitemid 32847844)
4. Frieden IJ, Haggstrom AN, Drolet BA, et al., Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005; 22: 383-406. (Pubitemid 43960991)
5. Enjolras O, BreviÃre GM, Roger G, et al., Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004; 11: 99-107. (Pubitemid 38220704)
6. Léauté-LabrÃze C, Dumas de la Roque E, Hubiche T, et al., Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651. (Pubitemid 351831393)
7. Manunza F, Syed S, Laguda B, et al., Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162: 466-468.
8. Ho NT, Lansang P, Pope E,. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 2007; 56: 63-68. (Pubitemid 46016997)
9. Pope E, Krafchik BR, Macarthur C, et al., Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007; 119: e1239-e1247. (Pubitemid 46871240)
10. Sans V, de la Roque ED, Berge J, et al., Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423-e431.
11. Storch CH, Hoeger PH,. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274.
12. D'Angelo G, Lee H, Weiner RI,. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997; 67: 353-366. (Pubitemid 27509471)
13. Sommers Smith SK, Smith DM,. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002; 38: 298-304. (Pubitemid 35204978)
14. Annabi B, Lachambre MP, Plouffe K, et al., Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 2009; 60: 438-445.
15. Léauté-Labrãze C, Táb A,. Efficacité des bêtabloquants dans les hémangiomes capillaires infantiles: signification physiopathologique et conséquences thérapeutiques. Ann Dermatol Venereol 2008; 135: 860-862.
16. Siegfried EC, Keenan WJ, Al-Jureidini S,. More on propranolol for hemangiomas of infancy. N Engl J Med 2008; 359: 2846.
17. Holland KE, Frieden IJ, Frommelt PC, et al., Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010; 146: 775-778.